Additional Information
Book Details
Abstract
This issue of Anesthesiology Clinics covers the latest updates in transplantation written by the world-leading experts on the topic. Procedurally-focused articles cover best practices in patient selection, intraoperative care, postoperative care, organ donor management and more. Achieve the best outcomes and keep current on this area of anesthesia practice.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Abdominal Transplantation \r | i | ||
Copyright\r | ii | ||
Contributors | iii | ||
Contents | v | ||
Anesthesiology Clinics\r | viii | ||
Preface\r | ix | ||
Advances in Transplantation 1940–2014 | 645 | ||
Key points | 645 | ||
Introduction | 645 | ||
Kidney transplantation | 646 | ||
Liver transplantation | 648 | ||
Coagulopathy | 651 | ||
Cardiovascular System | 653 | ||
Pancreas and Islet Transplantation | 654 | ||
Intestinal Transplantation | 654 | ||
The Future of Transplantation | 655 | ||
References | 655 | ||
Infrastructure, Logistics and Regulation of Transplantation | 659 | ||
Key points | 659 | ||
Introduction | 659 | ||
Logistics | 659 | ||
Oversight of transplantation | 662 | ||
Summary | 665 | ||
References | 666 | ||
Allocation of Resources for Organ Transplantation | 667 | ||
Key points | 667 | ||
Introduction | 667 | ||
Historical perspective | 668 | ||
Allocation | 670 | ||
Regions, Donation Service Areas, and OPO | 670 | ||
Kidney Allocation | 671 | ||
Pancreas Allocation | 672 | ||
Liver Allocation | 672 | ||
Dual Organ Allocation | 673 | ||
Summary | 673 | ||
References | 673 | ||
Ethics of Transplantation | 675 | ||
Key points | 675 | ||
Introduction | 675 | ||
Ideal, standard, and nonstandard organs for transplants | 677 | ||
Interventions to optimize successful donation and transplantation | 679 | ||
Best Interests and Overall Benefit | 680 | ||
Balancing Harm and Benefit | 681 | ||
NSD organs: recipient consent and liability | 682 | ||
Summary | 683 | ||
Acknowledgments | 684 | ||
References | 684 | ||
Patient Selection and Preoperative Evaluation for Transplant Surgery | 689 | ||
Key points | 689 | ||
Introduction | 689 | ||
Kidney transplantation | 691 | ||
Cardiovascular disease | 692 | ||
Identification of CAD | 692 | ||
Other Tests for CAD | 693 | ||
Management of CAD | 693 | ||
Other Cardiac Issues | 694 | ||
Liver transplantation | 694 | ||
Selection for liver transplantation | 694 | ||
Cardiovascular disease | 695 | ||
Coronary Artery Disease | 696 | ||
Screening for CAD | 696 | ||
Troponin | 697 | ||
Management of CAD | 697 | ||
Exercise Testing | 697 | ||
Other cardiac considerations | 697 | ||
Valvular Disease | 697 | ||
Left Ventricular Outflow Tract Obstruction | 698 | ||
Cirrhotic Cardiomyopathy | 698 | ||
Pulmonary and pulmonary vascular disease | 698 | ||
Hepatopulmonary Syndrome | 698 | ||
Portopulmonary Hypertension | 698 | ||
Other organs | 699 | ||
References | 699 | ||
Intraoperative Care of the Transplant Patient | 705 | ||
Key points | 705 | ||
Renal transplantation | 705 | ||
Brief Overview | 705 | ||
Transplant Recipient—Anesthetic Management | 706 | ||
Anesthetic Choice | 706 | ||
Monitoring | 706 | ||
Vascular Access | 707 | ||
Induction | 707 | ||
Fluid Management | 708 | ||
Hemodynamic Management | 708 | ||
Discussion of Adjuvant Drugs | 708 | ||
Emergence | 709 | ||
The Living Donor | 709 | ||
Induction | 709 | ||
Maintenance | 709 | ||
Fluid management | 710 | ||
Liver transplantation | 710 | ||
Brief Overview | 710 | ||
Transplant Recipient—Anesthetic Management | 710 | ||
Anesthetic Choice | 711 | ||
Monitoring | 711 | ||
Vascular Access | 711 | ||
Induction and Maintenance | 711 | ||
Fluid Management and Transfusion | 712 | ||
Hemodynamic Management | 714 | ||
Discussion of Adjuvant Drugs | 714 | ||
The Living Donor | 715 | ||
Induction | 715 | ||
Maintenance | 715 | ||
Fluid management | 716 | ||
Pancreas transplantation | 716 | ||
Intraoperative Management | 716 | ||
Intestinal transplantation | 717 | ||
References | 717 | ||
Postoperative Care/Critical Care of the Transplant Patient | 723 | ||
Key points | 723 | ||
Introduction | 723 | ||
Early assessment of allograft function | 724 | ||
Optimal support of the transplanted allograft | 727 | ||
Recognition and management of early complications | 728 | ||
Infectious Complications | 728 | ||
Pulmonary Complications | 729 | ||
Cardiac Complications | 730 | ||
Renal Complications | 731 | ||
Summary | 732 | ||
References | 732 | ||
Current Research on Organ Donor Management | 737 | ||
Key points | 737 | ||
Introduction | 737 | ||
Cardiovascular system | 738 | ||
Pulmonary system | 738 | ||
Endocrine system | 740 | ||
Vasopressin | 740 | ||
Thyroxine | 740 | ||
Steroids | 741 | ||
Renal system | 741 | ||
Hepatic system | 741 | ||
Pancreas | 742 | ||
Coagulation and thermoregulation disorders | 742 | ||
Donor management goals | 742 | ||
Considerations during organ recovery | 743 | ||
Summary and future directions | 744 | ||
References | 744 | ||
Transplantation in ACOs | 749 | ||
Key points | 749 | ||
Introduction | 749 | ||
HMOs | 751 | ||
PCMHs | 752 | ||
Patient Protection and Affordable Care Act of 2010 | 752 | ||
Accountable Care Organizations | 753 | ||
ACOs: what is known? | 753 | ||
Past pilot programs and ongoing initiatives | 754 | ||
National survey of hospital readiness to participate in an ACO | 755 | ||
Organ transplantation and the ACO approach | 756 | ||
Key questions to consider and next steps for ACOs | 759 | ||
Summary | 760 | ||
References | 760 | ||
Index | 763 |